Major Depressive Disorder

How does psychiatry access differ among patients, and how should it become individualized?

With ARBs linked to a higher risk of suicide, investigators suggest treating diseases like hypertension, chronic kidney disease, heart failure, and diabetes with ACEIs instead.

While depression does not impact functional recovery much following discharge, both dementia and delirium could affect a geriatric patient’s functional status.

Investigators suggest an upgrade to the existing categorical frameworks for diagnosing mental illnesses, such as obsessive-compulsive disorder and generalized anxiety disorder.

In a new meta-analyses, investigators find a lack of evidence showing the links between antidepressants and adverse health risks.

Investigators deem phase 2 study using pimavanserin to treat major depressive disorder a success.

Investigators find zolpidem effectively reduces suicidal ideation, particularly for patients suffering from severe insomnia symptoms.

While there are many options to treat depression, a balance of therapy and medication is often seen as the best method.

Bipolar depression can be difficult to treat and is often misdiagnosed.

Despite being commonly prescribed as an antidepressant, investigators find sertraline more effective at alleviating anxiety symptoms.

A new study shows that approximately one-quarter of adults aged 18-34 years old with a medical condition have used marijuna in the past month.

A clinical discussion on the underlooked, undertreated, and underperforming facets of a public health crisis.

Acadia Pharmaceuticals has announced positive findings for time to psychosis relapse in dementia patients, which resulted in the trial's early end.

Recent research advances have associated the gut's health to overall patient health. What do we know now?

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

In a double-blind, phase 2 trial, investigators find that SAGE-17 results in a reduction of depressive symptoms after 2 weeks.

In honor of National Suicide Prevention Week, Simon Rego, PsyD, and colleagues from Montefiore will look at suicide from a public health and clinical scope.

A new set of 22 recommendations include a combination of universal screenings, medication, and other preventative initiatives in an effort to drive down veteran suicide rates.

Despite a common belief that medications treating mental illnesses are connected to weight gain, new data shows an individual in a weight management program will lose weight whether or not they are taking antidepressants or antipsychotics.

A pattern of poor sleep could lead to worsened psychiatric wellbeing—and eventually, memory loss.

In a new study, investigators examine the efficacy and tolerability of antipsychotic medications for patients in remission for psychotic depression.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

The association of depression symptoms with cognition and cortical amyloid measurements could lead to better therapies to prevent Alzheimer disease.

In a new multivariable regression study, investigators link depression with a lack of social support and increased IBD activity.

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

A conventional mass-univariate fMRI analysis helps determine patients that exhibit greater pretreatment neural activity.

New research shows esketamine nasal spray could help treat patients who do not respond to antidepressants.